Trio Medicines
UK - LondonBiotechnology
Focus: Trio Medicines is a UK-based biotechnology company founded in 2007 focused on small molecules and biologics across oncology and gastrointestinal indications. The company operates as a mid-stage clinical-phase biotech with a diversified pipeline in early development.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
4 added, 2 removed. Backfill posture.
Should You Work at Trio Medicines?
AI assessmentTrio is a niche early-stage biotech offering technical depth in multi-indication drug development but presenting significant uncertainty around growth, hiring, and financial viability that requires due diligence before committing.
Why Work Here
- Exposure to multi-indication platform approach: YF476 is being developed across 5+ gastrointestinal indications (Barrett's Esophagus, Chronic Atrophic Gastritis, Zollinger-Ellison Syndrome, Hypergastrinaemia, Reflux Oesophagitis), offering deep expertise in indication expansion strategy.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
YF476
HypergastrinaemiaClinical Trials (1)
NCT01699113Effects of YF476 and Rabeprazole on Gastric Function
Phase 1Help build intelligence for Trio Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.